BASEL, Switzerland — Novartis here announced last week it won over-the-counter approval from the U.S. Food and Drug Administration for Proton Pump Inhibitor Prevacid 24HR (lansoprazole delayed-release capsules 15 mg). This is the first OTC PPI treatment of frequent heartburn since 2003, the company said in a statement. Prescription-strength Prevacid 24HR treats frequent heartburn for a full 24 hours. Used once daily, Prevacid 24HR works by stopping the release of acid into the stomach. ...

REGISTER TO VIEW THIS ARTICLE - Register for a Free Account

Why Register for FREE?

Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.  What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
 

Click here to read the FAQ page if you have any questions (opens in a new window)
 

Attention Paid Print Subscribers:  While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.

Already registered? here.